Web Analytics

3 Latest Announced Rounds

  • $10,500,000
    Unknown

    1 Investors

    HVAC and Refrigeration Equipment Manufacturing
    Nov 5th, 2024
  • $4,000,000
    Series A
    Financial Services
    Nov 5th, 2024
  • $1,000,000
    Pre-Seed
    Data Infrastructure and Analytics
    Nov 5th, 2024
$1,346.48M Raised in 66 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Receptor Life Sciences, Inc.

start up
United States - Seattle, Washington
  • 07/04/2022
  • Series A
  • $9,700,000

Receptor Life Sciences combines proven drug delivery technologies, compelling therapeutic candidates, and traditional drug development research practices to pursue a robust range of prescription drug treatments for CNS indications.

The delivery technologies, used in both oral and inhaled FDA-approved prescription drug products, represent a validated, strategic approach to overcoming traditional challenges of cannabinoid medicine. Receptor’s patented product candidates hold the potential to provide prescription treatments for a range of unmet medical needs, including anxiety and agitation in autism.

More information is at www.ReceptorLife.com.


Related People

Mark TheeuwesFounder

Mark Theeuwes United States - Greater Philadelphia

Experienced Pharmaceutical Executive with a demonstrated history of working in all aspects of Clinical and Commercial Execution.